Related Experiment Video
Updated: Aug 11, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Th2 cytokine response in Major Depressive Disorder patients before treatment
Lenin Pavón1, Gabriel Sandoval-López, María Eugenia Hernández
1Department of Psychoimmunology, National Institute of Psychiatry Ramón de la Fuente, México.
Abstract:
In Major Depressive Disorder (MDD), the neuroendocrine and immune systems interactions are impaired. We investigated the pro/anti-inflammatory Th1/Th2 cytokine balance in MDD patients and in non-depressed control group. The MDD subjects showed higher levels of cortisol and TNF-alpha, increased CD3+CD8+ and NK percentages, diminished B cell counts and no significant variations in CD3+CD4+ lymphocyte. Moreover, higher levels of IL-4 and IL-13 (Th2) and significantly lower measurements of IL-2 and IFN-gamma (Th1) cytokines were also observed in the MDD group. Overall, we propose that all these changes could be related to the elevated cortisol levels seen in the MDD patients. Further studies are necessary to explore these findings and its implication in future therapeutic approach of MDD patients.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depression: Overview
